Le Wang

机构：University of Science and Culture, Shandong University, Shandong Provincial Hospital, Shandong First Medical University · ORCID：0000-0002-5023-1240

发表论文 35 篇 · 总被引 1550 次 · h-index 18

代表论文

• Triple‐Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases (2019 · Angewandte Chemie International Edition · 被引 143)
• Mitochondrial dysfunction in hearing loss: Oxidative stress, autophagy and NLRP3 inflammasome (2023 · Frontiers in Cell and Developmental Biology · 被引 70)
• Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells (2019 · EBioMedicine · 被引 68)
• Maize PPR-E proteins mediate RNA C-to-U editing in mitochondria by recruiting the trans deaminase PCW1 (2022 · The Plant Cell · 被引 63)
• Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy (2018 · ChemBioChem · 被引 62)
• Engineered commensal bacteria prevent systemic inflammation-induced memory impairment and amyloidogenesis via producing GLP-1 (2018 · Applied Microbiology and Biotechnology · 被引 53)